author-photo

Christine Macabre

University of Strasbourg

17

Papers

133

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction

2019 Cancers
Show All
- Source
- Cite
- Save
Citations (10)
Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties

2016 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties

2015 Oncotarget
Show All
- Source
- Cite
- Save
Citations (23)
From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression

2015 BMC Systems Biology
Show All
- Source
- Cite
- Save
Citations (18)
183: From ERa66 to ERa36: a new predictive marker for cancer progression and therapeutic response in breast tumors?

2014 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
ERalpha36, un marqueur prédictif de la réponse thérapeutique et du potentiel métastatique des tumeurs mammaires ?

2014
Show All
- Source
- Cite
- Save
Citations (0)
From here to ERalpha36, a new predictive marker for breast tumor therapeutic response ?

2013
Show All
- Source
- Cite
- Save
Citations (0)
A Poor Prognosis Subtype of HNSCC Is Consistently Observed across Methylome, Transcriptome, and miRNome Analysis

2013 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (40)
From ERα66 to ERα36, a new marker for breast tumor therapeutic response ?

2013
Show All
- Source
- Cite
- Save
Citations (0)